GlaxoSmithKline Intellectual Property Development Limited;National Institutes of Health
发明人:
David A. WILFRET,Jesse Daniel KEICHER,Helene Fischer ROSENBERG
申请号：
US15525329
公开号：
US20170333494A1
申请日:
2015.11.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Aspects of the present invention are related to the use of Lactobacillus species in a composition for respiratory administration to prevent the pathogenic inflammatory sequelae of respiratory virus infections.
